Avana Health
Avana Health is a women’s health company focused on developing treatments for women with significant unmet needs, particularly abnormal uterine bleeding (AUB) and postpartum hemorrhage (PPH). They aim to create safe, effective, affordable, and accessible uterine health treatments that improve quality of life and are easy for providers to use. Their mission aligns with the UN’s Sustainable Development Goals to reduce maternal mortality and improve health outcomes for women worldwide. The company is embarking on clinical trials for their innovative treatments.
Industries
Nr. of Employees
small (1-50)
Avana Health
Products
Treatment system for Abnormal Uterine Bleeding (AUB)
A combined drug and single-use device kit intended to provide a fast outpatient procedure for acute management of abnormal uterine bleeding without surgical intervention.
Treatment system for Postpartum Hemorrhage (PPH)
A combined drug and single-use device kit intended to provide a fast-acting, non-surgical treatment for catastrophic postpartum hemorrhage to complement standard pharmacologic care.
Avana Health Postpartum Hemorrhage Treatment System
A drug and device kit providing a fast outpatient procedure to address abnormal uterine bleeding and improve patients' quality of life, with rapid local cessation of blood flow and fertility preservation.
HemmoStat system
A system invented by Dr. John Morehead for obstetric and gynecologic applications, likely related to hemorrhage control.
Treatment system for Abnormal Uterine Bleeding (AUB)
A combined drug and single-use device kit intended to provide a fast outpatient procedure for acute management of abnormal uterine bleeding without surgical intervention.
Treatment system for Postpartum Hemorrhage (PPH)
A combined drug and single-use device kit intended to provide a fast-acting, non-surgical treatment for catastrophic postpartum hemorrhage to complement standard pharmacologic care.
Avana Health Postpartum Hemorrhage Treatment System
A drug and device kit providing a fast outpatient procedure to address abnormal uterine bleeding and improve patients' quality of life, with rapid local cessation of blood flow and fertility preservation.
HemmoStat system
A system invented by Dr. John Morehead for obstetric and gynecologic applications, likely related to hemorrhage control.
Services
Engagements with external partners for clinical development, regulatory strategy, and manufacturing to advance uterine treatment candidates.
Engagements with external partners for clinical development, regulatory strategy, and manufacturing to advance uterine treatment candidates.
Expertise Areas
- Uterine therapeutics development
- Postpartum hemorrhage (PPH) treatment development
- Abnormal uterine bleeding (AUB) treatment development
- Drug–device combination products
Key Technologies
- Drug–device combination
- Local hemostatic drug formulation
- Single-use sterile uterine device engineering
- Quantitative blood-loss collection/measurement